Literature DB >> 24691560

Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.

Ferrán Catalá-López1, Aurelio Tobías, Chris Cameron, David Moher, Brian Hutton.   

Abstract

Systematic reviews and meta-analyses of randomized trials have long been important synthesis tools for guiding evidence-based medicine. More recently, network meta-analyses, an extension of traditional meta-analyses enabling the comparison of multiple interventions, use new statistical methods to incorporate clinical evidence from both direct and indirect treatment comparisons in a network of treatments and associated trials. There is a need to provide education to ensure that core methodological considerations underlying network meta-analyses are well understood by readers and researchers to maximize their ability to appropriately interpret findings and appraise validity. Network meta-analyses are highly informative for assessing the comparative effects of multiple competing interventions in clinical practice and are a valuable tool for health technology assessment and comparative effectiveness research.

Mesh:

Substances:

Year:  2014        PMID: 24691560     DOI: 10.1007/s00296-014-2994-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  40 in total

1.  Network meta-analysis for indirect treatment comparisons.

Authors:  Thomas Lumley
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

2.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

Authors:  Georgia Salanti; A E Ades; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2010-08-05       Impact factor: 6.437

Review 3.  Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales.

Authors:  John P A Ioannidis; Fotini B Karassa; Eric Druyts; Kristian Thorlund; Edward J Mills
Journal:  Nat Rev Rheumatol       Date:  2013-09-03       Impact factor: 20.543

4.  Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis.

Authors:  Robert Launois; Bernard Avouac; Francis Berenbaum; Olivier Blin; Isabelle Bru; Bruno Fautrel; Jean-Michel Joubert; Jean Sibilia; Bernard Combe
Journal:  J Rheumatol       Date:  2011-01-15       Impact factor: 4.666

5.  Adjustment for reporting bias in network meta-analysis of antidepressant trials.

Authors:  Ludovic Trinquart; Gilles Chatellier; Philippe Ravaud
Journal:  BMC Med Res Methodol       Date:  2012-09-27       Impact factor: 4.615

6.  Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study.

Authors:  Fujian Song; Tengbin Xiong; Sheetal Parekh-Bhurke; Yoon K Loke; Alex J Sutton; Alison J Eastwood; Richard Holland; Yen-Fu Chen; Anne-Marie Glenny; Jonathan J Deeks; Doug G Altman
Journal:  BMJ       Date:  2011-08-16

7.  The effects of excluding treatments from network meta-analyses: survey.

Authors:  Edward J Mills; Steve Kanters; Kristian Thorlund; Anna Chaimani; Areti-Angeliki Veroniki; John P A Ioannidis
Journal:  BMJ       Date:  2013-09-05

Review 8.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Authors:  Deborah M Caldwell; A E Ades; J P T Higgins
Journal:  BMJ       Date:  2005-10-15

9.  Evidence synthesis for decision making 1: introduction.

Authors:  Sofia Dias; Nicky J Welton; Alex J Sutton; A E Ades
Journal:  Med Decis Making       Date:  2013-07       Impact factor: 2.583

10.  Characteristics of networks of interventions: a description of a database of 186 published networks.

Authors:  Adriani Nikolakopoulou; Anna Chaimani; Areti Angeliki Veroniki; Haris S Vasiliadis; Christopher H Schmid; Georgia Salanti
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  64 in total

1.  Comparing Interventions for Management of Hot Flashes in Patients With Breast and Prostate Cancer: A Systematic Review With Meta-Analyses.

Authors:  Brian Hutton; Mona Hersi; Wei Cheng; Misty Pratt; Pauline Barbeau; Sasha Mazzarello; Nadera Ahmadzai; Becky Skidmore; Scott C Morgan; Louise Bordeleau; Pamela K Ginex; Behnam Sadeghirad; Rebecca L Morgan; Katherine Marie Cole; Mark Clemons
Journal:  Oncol Nurs Forum       Date:  2020-07-01       Impact factor: 2.172

2.  Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Gwan Gyu Song; Young Ho Lee
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

3.  Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2017-12       Impact factor: 1.372

4.  Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2015-05-21       Impact factor: 2.631

5.  Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

Authors:  S-C Bae; Y H Lee
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

6.  Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

Review 7.  Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

8.  Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis : A Bayesian network meta-analysis of randomized controlled trials.

Authors:  S-C Bae; Y H Lee
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

Review 9.  Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis.

Authors:  Jun Zhang; Bo Wang; Rongke Li; Long Ge; Kee-Hsin Chen; Jinhui Tian
Journal:  Int Urol Nephrol       Date:  2016-12-29       Impact factor: 2.370

10.  Enhancing the quality and transparency of systematic reviews.

Authors:  Herney Andrés García-Perdomo
Journal:  Colomb Med (Cali)       Date:  2018-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.